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Abstract 
     Two new cryptic 3,4-dihydronaphthalen-(2H)-1-one (1-tetralone) derivatives, aspvanicin A 
(1) and its epimer aspvanicin B (2), as well as several known cryptic metabolites (3-8), were 
obtained from the ethyl acetate extract of the co-culture of the endophytic fungus Aspergillus 
versicolor KU258497 with the bacterium Bacillus subtilis 168 trpC2 on solid rice medium. 
When A. versicolor was cultured axenically in liquid Wickerham medium supplemented with 
3.5% DMSO, an additional three known secondary metabolites (9-11) were isolated that were 
lacking when the fungus was fermented on rice medium. The structures of the new compounds 
were elucidated using one- and two-dimensional NMR spectroscopy as well as HRESIMS. The 
relative and absolute configurations of 1 and 2 were determined by the combination of NMR 
and electronic circular dichroism (ECD) analysis aided by DFT conformational analysis and 
TDDFT-ECD calculations. The ECD calculations revealed that although the sign of the blue-
shifted overlapping n-π* ECD transition follows the helicity rule of cyclic aryl ketones, the 
calculation of low-energy conformers and ECD spectra was necessary to determine the 
stereochemistry. All metabolites were assessed for their antibacterial and cytotoxic activities; 
one of the new diastereomers, compound 2, showed moderate cytotoxic activity against the 
mouse lymphoma cell line L5178Y. 
 
Keywords: Aspergillus versicolor; Tetralone derivatives; Absolute configuration; ECD 
calculations 
 
Introduction 
     Endophytic fungi represent a promising and still largely untapped reservoir of biologically 
active secondary metabolites with potential for exploitation in the pharmaceutical industry.
1,2
 
Aspergillus is one of the oldest fungal genera known to science, having been described for the 
first time in 1729.
3
 Aspergillus versicolor is widespread in different habitats (plants, marine, air 
dust and soil), and has the ability to survive under extreme natural environmental conditions 
that are usually unfavourable for growth.
4-6
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     Co-cultivation of fungi with bacteria (mixed fermentation) has in many cases been shown to 
trigger the accumulation of new cryptic secondary metabolites or to enhance the production of 
constitutively present compounds through the activation of silent biosynthetic pathways.
7,8
 This 
technique attempts to mimic natural microbial communities where fungi and bacteria co-exist 
and interact in a competitive manner for nutrients.
9,10
 The co-cultivation of several species of 
Aspergillus with different bacteria has proved to be a powerful tool to enrich the chemical 
diversity of these fungi. Representative examples include: two antibacterial compounds, 
fumicycline A and fumicylcline B, from the co-cultivation of A. fumigatus with Streptomyces 
rapamycinicus,
11
 and co-cultivation of the endophytic fungus A. austroafricanus with Bacillus 
subtilis or with Streptomyces lividans which led to the accumulation of the new diphenyl ether 
austramide.
12
 In a recent study, Proksch and co-workers reported the isolation of a new 
cytotoxic dihydroquinolone derivative aflaquinolone H along with two new dimeric 
isocoumarins (6,6’,9’-trinor-bipenicillisorin and 6,6’-dinor-bipenicillisorin), from the same 
endophytic fungus A. versicolor KU258497.13 This encouraged us to conduct a co-cultivation 
experiment of this fungus with the bacterium B. subtilis with the aim to stimulate silent 
biogenetic gene clusters. 
     In addition to co-cultivation, the OSMAC (One Strain MAny Compounds) approach is 
considered an important technique to enhance the chemical diversity of fungal metabolites.
14
 
Even slight alterations of culture conditions (e.g. different temperature, culture media, light 
conditions, pH, carbon source, nitrogen source, culture vessels) may have a pronounced 
influence on the accumulation of fungal natural products.
8
 Examples illustrating the usefulness 
of this technique include the replacement of water in solid rice media by either fruit or 
vegetable juices which led to an 80-fold increase in the accumulation of the new cytotoxic 
compound fusarielin J, as well as the biosynthesis of two new compounds, fusarielin K and L, 
by the endophytic fungus Fusarium tricinctum.
15
 When the marine derived fungus Aspergillus 
terreus was grown on different media,
 
malt agar and barley-spelt solid media were shown to 
induce the new cytotoxic compound 7-desmethylcitreoviridin.
16
 In the present study, an 
OSMAC approach was applied for the cultivation of the fungus A. versicolor KU258497 in 
liquid Wickerham medium supplemented with 3.5% DMSO as a stress factor.
8
 
     Using co-cultivation or the OSMAC approach as tools, we succeeded in the isolation of two 
new dihydronaphthalenone derivatives, aspvanicin A (1) and its diastereomer aspvanicin B (2), 
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as well as six known cryptic metabolites including methyl orsellinate (3),
17
 orsellinic acid (4),
18
 
cordyol C (5),
19
 sydowiol B (6),
20
 p-hydroxybenzaldehyde (7)
21
 and fusarubin (8).
22
 Moreover, 
cultivation of the fungus in liquid Wickerham medium supplemented with 3.5% DMSO 
yielded the known compounds sterigmatocystin (9),
23
 infectopyrone (10)
24
 and versiol (11).
25
 
All isolated compounds (Fig. 1) were investigated for their antibacterial, antitubercular and 
cytotoxic activity against the mouse lymphoma cell line L5178Y. 
 
 
Figure 1. Structures of the isolated compounds 
 
Results and Discussion 
     Compound 1 was isolated as a pale brown amorphous solid from the EtOAc extract of the 
fungal bacterial co-cultivation. ESI-HRMS showed a pseudomolecular ion peak at m/z 
295.1173 [M+H]
+
 (calculated for 295.1176 C15H19O6) indicating seven degrees of unsaturation. 
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The UV spectrum showed absorption maxima at 208, 243 and 285 nm which are characteristic 
of dihydronaphthalenones.
26
 The 
13
C NMR data (Table 1) showed 15 different carbons grouped 
into seven quaternary carbons, including two carbonyl carbons (δC 203.2, 208.3), three 
oxygenated aromatic carbons (δC 137.6, 156.8, 158.0) and two non-oxygenated aromatic 
carbons (δC 128.0, 108.0). Moreover, the 
13
C NMR data revealed the presence of two methoxy 
groups, one aromatic (δC 56.6) and one aliphatic (δC 57.1), one methyl group (δC 31.1), one 
aromatic tertiary carbon (δC 100.4), two aliphatic tertiary carbons, including one oxygenated 
(δC 70.7) and one non-oxygenated carbon (δC 35.4), and two secondary aliphatic carbons (δC 
38.0, 45.5).  
     The 
1
H-NMR data (Table 1) displayed one aromatic proton at δH 6.54 (s, H-7), one methyl 
group at δH 2.14 (s, H3-11), two methoxy groups, including a methoxy substituent at an 
aromatic ring at δH 3.90 (s, H3-12) and an aliphatic methoxy at δH 3.20 (s, H3-13). Furthermore, 
the 
1
H-NMR data exhibited two methylene groups [δH 2.34 (dd, J = 4.1, 17.3 Hz, Ha-2), δH 
2.58 (m, Hb-2) and δH 2.60 (dd, J = 6.5, 17.5 Hz, Ha-9), δH 2.84 (dd, J = 6.7, 17.5 Hz, Hb-9)]. 
In addition, two methine signals were detected at δH 4.70 (d, J = 1.8 Hz, H-4) and at δH 2.49 
(m, H-3). Moreover, the 
1
H-NMR spectrum showed two hydroxyl groups, one at 8.66 (s, OH-
5) ppm and a chelated OH group at 12.63 (s, OH-8) ppm. 
     Based on UV, 
1
H and 
13
C NMR data (Table 1) combined with the molecular formula 
obtained from ESI-HRMS, compound 1 revealed a close structural similarity to the previously 
reported dihydronaphthalenone derivative, 4-hydroxydihydronorjavanicin.
26
 The main 
difference between 1 and 4-hydroxydihydronorjavanicin lies in the presence of an extra 
aliphatic methoxy group resonating at δH 3.20 (s, H3-13). This is also reflected in the difference 
in the molecular weight between 1 and 4-hydroxydihydronorjavanicin amounting to 14 amu. 
The planar structure of 1 was confirmed via 2D NMR spectral analyses including 
1
H-
1
H 
COSY, HMBC and ROESY experiments (Fig. 2). The 
1
H-
1
H COSY spectrum displayed a 
solitary spin system CH2(2)CH(3)CH2(9)CH(4) as depicted in Figure 2. Furthermore, the 
HMBC spectrum (Fig. 2) revealed correlations from the aromatic proton H-7 to C-5 (δC 137.6), 
C-6 (δC 156.8), C-8 (δC 158.0) and C-8a (δC 108.0). The methoxy groups OCH3-12 and OCH3-
13 were present at C-6 and C-4, respectively, as revealed by their HMBC correlations from 
OCH3-12 to C-6 (along with its ROESY correlation with H-7) and from OCH3-13 to C-4 (δC 
70.7). Further inspection of the HMBC spectrum revealed correlations from CH2-9 to C-4 and 
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C-10 (δC 208.3) in addition to correlations from Ha-2 to C-1 (δC 203.2) and from H-4 to C-2 
(δC 38.0), C-8a and C-13 (δC 57.1). Moreover, Hb-2 showed a cross peak with C-4 and H-3 
correlated with C-10. The position of the methyl group CH3-11 was unambiguously confirmed 
by correlation of its protons with C-10 and similarly the position of the chelated hydroxyl 
group OH-8 was secured by key correlations with C-7 (δC 100.4), C-8 and C-8a, along with its 
ROESY correlation with H-7. The hydroxyl group OH-5 showed correlations with C-4a (δC 
128.0), C-5 and C-6 confirming the planar structure of 1 as depicted in Figure 1. The relative 
configuration of 1 was deduced on the basis of coupling constants and ROESY data. Inspection 
of the ROESY spectrum revealed correlations between H2-9 and both H-4 and OCH3-13, 
which along with the small coupling constant (1.8 Hz) between H-4 and H-3 suggested their 
cis relationship (Fig. 2). Based on the aforementioned data, compound 1 was assigned as a new 
dihydronaphthalenone derivative to which the trivial name aspvanicin A is given. 
     Compound 2 was obtained as a pale brown amorphous solid. ESI-HRMS indicated a 
pseudomolecular ion peak at m/z 295.1178 [M+H]
+
 (calculated for 295.1176 C15H19O6), 
identical to that of compound 1. The UV (MeOH) spectrum of 2 revealed absorption maxima 
(λmax) at 208, 243 and 285 nm which were also identical to those of 1, indicating that 
compound 2 belongs to the dihydronaphthalenone class of compounds.
26
 In fact, the 
1
H and 
13
C 
NMR data of compounds 1 and 2 were very similar, except for the 
1
H NMR chemical shifts of 
H2-2, H-3 and H2-9 (Table 1). 
1
H-
1
H COSY and HMBC spectral analysis (Fig. 2) confirmed 
the substitution pattern as shown in Figure 1. 
     ROESY correlations and 
3
JH,H coupling constants aided by DFT conformational analysis 
were used to determine the relative configuration and preferred conformation of compounds 1 
and 2. In both compounds, ROESY cross peaks from H-4 to both H-3 and H2-9 were observed, 
while no ROE correlation was detected between H-4 and H2-2. However, whereas in 
compound 1, a weak ROESY correlation from OCH3-13 to Hb-9 was found, this was not 
detected in compound 2. These ROE data along with the 
3
JH-3,H-4 coupling constants (1.8 Hz in 
1 and 3.1 Hz in 2) suggested that compound 1 is the cis diastereomer with equatorial C-3 and 
axial C-4 substituents, while compound 2 is the trans diastereomer with diaxial orientation of 
the C-3 and C-4 substituents, which was also confirmed by the DFT conformational analysis 
(vide infra). Compound 2 is further example of natural products, in which the small 
3
JH,H 
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coupling constant for the methine protons of adjacent chirality centers of a condensed six-
membered ring does not derive from cis relative configuration but instead the six-membered 
ring preferably adopts a conformation with trans-diaxial orientation of the adjacent 
substituents.
27
 Thus, compound 2 was shown to be a diastereomer of the co-isolated aspvanicin 
A (1) to which the trivial name aspvanicin B is given. 
     Both aspvanicin A (1) and B (2) contain a substituted 1-tetralone (3,4-dihydronaphthalene-
1(2H)-one) chromophore with two chiral centers at the C-3 and C-4 positions of the fused 
cyclohexanone ring, which offers the possibility to determine the absolute configuration and 
preferred conformation of 1 and 2 by ECD measurements and TDDFT-ECD calculations. This 
chromophore belongs to the group of cyclic aryl ketones, which also includes 2,3-
dihydroquinoline-4(1H)-one,
27
 flavanones,
28
 2-alkylchromanones,
29
 and isoflavanones.
30,31
 The 
sign of the long-wavelength n-π* cotton effect (CE) of these chromophores were correlated 
with the helicity of the condensed six-membered ring, according to which M helicity of the 
ring results in a negative n-π* CE. Since the preferred M/P helicity of the ring is governed by 
the chiral centers, the sign of the n-π* CE can allow the absolute configuration to be 
determined. Although the same correlation (helicity rule) is expected for the 1-tetralone 
chromophore,
32
 our recent ECD calculations on conformationally restricted condensed,
33,34
 and 
bridged
35
 1-tetralone natural products showed that auxochromic substituents such as hydroxyl 
or alkoxy groups on the condensed benzene ring can induce a red-shift of the π-π* transition, 
while a chelating 8-OH group can shift the n-π* CE to a lower wavelength. Thus, the π-π* 
transition becomes the highest-wavelength transition and n-π* CE overlaps with other π-π* 
transitions rendering determination of the absolute configuration ambiguous by the helicity 
rule. TDDFT-ECD calculations of 1-tetralone derivatives are recommended for 8-hydroxy 
derivatives and with other auxochromic substituents on the benzene ring or with 
conformationally flexible cyclohexenone rings.
36
 
     The absolute configuration of 1 and 2 was determined by thorough conformational analysis 
and the solution TDDFT-ECD method.
37,38
 Near mirror image ECD spectra were recorded for 
1 and 2, which suggested the diastereomers have opposite helicity for the preferred low-energy 
conformers. The Merck Molecular Force Field (MMFF) conformational search of the 
arbitrarily chosen (3S,4S)-1 and (3S,4R)-2 resulted in 7 and 9 conformers, respectively, in a 21 
kJ/mol energy window. These conformers were reoptimized at the B3LYP/6-31G(d) and 
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CAM-B3LYP/TZVP PCM/MeCN levels yielding 4-6 low-energy conformers over 1% 
Boltzmann populations (ESI). The low-energy conformers differed virtually only in the 
conformation of the flexible C-3 substituent and in all preferred geometries of 1 and 2, the 4-
OCH3 group had an axial orientation,
27,39
 while the C-3 substituent was equatorial in 1 and 
axial in 2 which is in full agreement with the NMR results. The M helicity envelop 
conformation was found to be the exclusive computed conformation for (3S,4S)-1 with a 
torsional angle ωC4a-C4-C3-C2 = 58.9° (Fig. 2) and the P helicity conformation for 2 with a 
+57.5° angle (values for the lowest-energy CAM-B3LYP/TZVP PCM/MeCN conformers). 
ECD calculations for the conformers of (3S,4S)-1 and (3S,4R)-2 at various levels of theory 
(B3LYP/TZVP, BH&HLYP/TZVP, CAM-B3LYP/TZVP, PBE0/TZVP) gave mirror-image 
computed ECD spectra of the experimental one with substantially higher intensities (c.a. 8 
fold) suggesting scalemic mixtures with an excess of the (3R,4R) enantiomer of 1 and the 
(3R,4S) enantiomer of 2.
40
 In Figure 3 and 4, the small experimental intensities (Δε) of the 
recorded ECD spectra were multiplied by 8 in order to be comparable with the computed 
values, which suggested that the samples are not enantiopure but scalemic mixtures with an 
excess of the identified enantiomers. It is interesting to note that for 2 the BH&HLYP 
functional reproduced the 265 nm shoulder while the B3LYP and PBE0 functionals performed 
better in the low-wavelength region and gave no shoulder at 265 nm.
41
 For both compounds, 
the computed first and fourth high-wavelength transitions were found to be π-π* ones while the 
second and the third ones are of n-π* origin (Fig. 3 and 4). The second high-wavelength 
transition of (3S,4S)-1 was derived from the tetralone carbonyl n-π* and its negative CE was in 
accordance with the M helicity of (3S,4S)-1. This characteristic n-π* transition overlaps with a 
π-π* and the side-chain n-π*, which does not allow safe application of the n-π* helicity rule for 
configurational assignment. The blue-shift of the n-π* CE is attributed to the hydrogen-
bonding 8-OH group which chelates to the carbonyl oxygen and auxochromic 5-OH and 6-
OCH3 groups. Similarly, positive computed overlapping n-π* CE of the tetralone unit was 
identified as the second high-wavelength transition, which derives from the P helicity of 
(3S,4R)-2. Although the helicity rule of cyclic aryl ketones was found to be valid for the recent 
1-tetralones, its application is not feasible for configurational assignment due to the ambiguous 
identification of the n-π* CE without calculations. 
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Table 1. 
1
H and 
13
 C NMR data of compounds 1 and 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
 Measured in DMSO-d6 (
1
H NMR 600 MHz and 
13
C NMR 150 MHz) 
b
 Data were assigned and confirmed by HMBC and HSQC spectra 
Position 
1 2 
δH
a
,
 
mult. (J in Hz) δC
a,b
, type  δH
a
, mult. (J in Hz)
                                                    
 δC
a,b
, type 
1  203.2, C  202.0, C 
2 2.34, dd (4.1, 17.3) 38.0, CH2  2.23 br d (17.8) 37.4, CH2 
 2.58, m   2.97, dd (5.4, 17.8)  
3 2.49, m 35.4, CH  2.86, m 31.0, CH 
4 4.70, d (1.8) 70.7, CH  4.61, d (3.1) 72.4, CH 
4-a  128.0, C  124.0, C 
5  137.6, C   138.9, C 
6  156.8, C   156.6, C 
7 6.54, s 100.4, CH  6.54, s  99.7, CH 
8  158.0, C  158.7, C 
8-a  108.0, C  108.0, C 
9 2.60, dd (6.5, 17.5) 45.5, CH2  2.30, m 43.9, CH2 
 2.84, dd (6.7, 17.5)    
10  208.3, C   208.0, C 
11                            2.14, s 31.1, CH3 2.01, s 29.7, CH3 
12 3.90, s 56.6, CH3 3.89, s 56.0, CH3 
13 3.20, s 57.1, CH3 3.28, s 56.0, CH3 
OH-5 8.66, s  8.63, s  
OH-8 12.63, s  12.59, s  
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Figure 2. (a) Key 
1
H-
1
H COSY and HMBC correlations of compounds 1 and 2. (b) Selected 
ROESY correlations of 1 and 2 (lowest-energy computed conformers). (c) and (d) Different 
conformers of compounds 1 and 2. 
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Figure 3. Experimental ECD spectrum (black) of 1 in MeCN compared with the Boltzmann-
weighted BH&HLYP/TZVP PCM/MeCN ECD spectrum (blue) of (3S,4S)-1 computed for the 
5 low-energy CAM-B3LYP/TZVP PCM/MeCN conformers. The bars represent the rotational 
strength of the lowest-energy conformer. 
 
 
Figure 4. Experimental ECD spectrum (black) of 2 in MeCN compared with the Boltzmann-
weighted BH&HLYP/TZVP PCM/MeCN (blue) and PBE0/TZVP PCM/MeCN (red) ECD 
spectra of (3S,4R)-2 computed for the 6 low-energy CAM-B3LYP/TZVP PCM/MeCN 
conformers. The bars represent the rotational strength of the lowest-energy conformer 
computed at the BH&HLYP/TZVP PCM/MeCN level. 
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     Compound 1 is closely related to the reported 4-hydroxydihydronorjavanacin, which 
contains a cis 4-OH substituent instead of the cis-4-OCH3 of 1.
26 
However, the reported 4.7 Hz 
value for the 
3
J3-H,4-H lies closer to the 3.1 Hz value of trans-2 than to the 1.8 Hz of 1 and the 
reported NOE correlation between 2-Hax and 4-Hax derives from minor conformers with a 
diequatorial orientation of C-3 and C-4 substituents. Thus, it is likely that 4-
hydroxydihydronorjavanacin has a trans relative configuration and similarly to 2, the C-3 and 
C-4 substituents adopts mainly diaxial orientation. Our recent results emphasize that a small 
3
JH,H coupling constant of methine protons of contiguous chiral centers in a six-membered ring 
does not necessarily mean a cis relative configuration and combination with DFT 
conformational analysis and ECD calculation can help to deduce the stereochemistry. 
     The presence of compounds 1 and 2 in the crude EtOAc extract of A. versicolor, as detected 
by their retention times and UV patterns in HPLC (ESI), suggests that both compounds are true 
natural products and not formed from their respective demethyl derivatives during 
chromatographic work up.  
      Interestingly, the isolated metabolites (1-8) from the extract of the co-culture of A. 
versicolor with B. subtilis in the present study were never detected nor isolated from the axenic 
fungal
13
 nor bacterial cultures, as it is clearly indicated in the HPLC chromatograms (ESI). 
These results provide a further example indicating that fungal-bacterial co-cultivation is a 
powerful tool which could effectively induce the production of new and cryptic secondary 
metabolites. 
     All isolated compounds were assessed for their antiproliferative activity against the mouse 
lymphoma cell line L5178Y using the MTT assay. Among the tested compounds, only 
aspvanicin B (2) and compound 9 showed cytotoxic activity with IC50 values of 22.8 and 2.2 
μM, respectively, compared to kahalalide F as a standard antiproliferative agent (IC50 = 4.3 
μM). Moreover, all compounds were evaluated for their antibacterial activities against several 
Gram-positive and Gram-negative bacteria, within a concentration range of 0–100 μM. Only 
compound 6 revealed weak antibacterial activity against Staphylococcus aureus (ATCC 
700699) with minimal inhibitory concentration (MIC) of 50 μM (19.2 μg/mL). 
     In conclusion, two new dihydronaphthalenone diastereomers, aspvanicin A (1) and 
aspvanicin B (2), were isolated from a co-culture of the endophytic fungus A. versicolor 
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KU258497 with the bacterium B. subtilis, along with several cryptic secondary metabolites (3-
8). Moreover, an OSMAC experiment afforded three further known cryptic metabolites (9-11). 
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Highlights: 
 OSMAC approach was applied for the fungus Aspergillus versicolor. 
 Co-culture of this fungus with Bacillus subtilis yielded two new tetralones.  
 ECD calculations were performed for the new tetralone derivatives. 
 
